Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: BATTELLE MEMORIAL INSTITUTE
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2018-02-09 to 2024-08-11
Current total value of award: $43256455.04
Description: THE DEPARTMENT OF DEFENSE (DOD) SUPPORTS THE DEVELOPMENT OF VACCINES THAT ARE DIRECTED AGAINST VALIDATED BIOLOGICAL WARFARE (BW) WEAPONS TO INCLUDE BACTERIA, VIRUSES, AND TOXINS OF BIOLOGICAL ORIGIN. VACCINES HAVE BEEN IDENTIFIED AS THE MOST EFFICIENT COUNTERMEASURE AGAINST THE VALIDATED THREAT OF BIOLOGICAL WARFARE WEAPONS. THE  FOLLOWING PRODUCT ARE IN DEVELOPMENT - BOTULINUM A/B, PLAGUE, TRIVALENT FILOVIRUS, RICIN, WEVEE, BURKHOLDERIA, TULI, AND NEXT GENERATION ANTHRAX.